当这些风险修正因子存在时，患者的ASCVD风险已经超越了算法计算的范畴。指南建议医生应充分考虑这些因素，可据此将患者重新分类到更高的风险类别。这彻底打破了既往分层中“非此即彼”的僵化界限，使得风险评估从变成了一个需要结合临床综合判断的分析题，极大地提 ...

The 2024 ESC Guidelines on the management of chronic coronary syndromes (CCS) include a focus on both larger and smaller blood vessels of the heart; new models to estimate chances of blocked large ...

London, UK, 30 August 2024: Updated ESC Guidelines on the management of elevated blood pressure and hypertension include a new elevated blood pressure category, more ambitious and intensive treatment ...

The 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (PAAD) evaluate these vascular diseases together as part of same cardiovascular system, appreciating that patients ...

Madrid, Spain – 29 August 2025: Updated ESC/EACTS Guidelines, being published today at ESC Congress 2025, aim to improve the way that patients with valvular heart disease are diagnosed and treated, ...

LONDON -- A set of new European guidelines streamlined recommendations for atrial fibrillation (Afib), chronic coronary disease, peripheral artery disease (PAD) and aortic disease, and hypertension, ...

The 2023 European Society of Cardiology (ESC) guidelines for acute and chronic heart failure (HF) include upgraded recommendations for intravenous (IV) iron supplementation, including Ferinject ® ...

Mundipharma Welcomes the New Guidelines from ESC/EASD Recommending First-Line use of Sodium-Glucose Co-transporter-2 Inhibitors for Type 2 Diabetes Patients with Cardiovascular Disease ...

The vast majority of experts who write and review some of the major clinical guidelines issued by the European Society of Cardiology (ESC), including those for ischemic heart disease, valvular heart ...